Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia

  • Ji Bak Kim,
  • Woo Hyuk Song,
  • Jong Sung Park,
  • Tae-Jin Youn,
  • Yong Hyun Park,
  • Shin-Jae Kim,
  • Sung Gyun Ahn,
  • Joon-Hyung Doh,
  • Yun-Hyeong Cho,
  • Jin Won Kim

The following information is missing from the Funding statement: This work was supported by the National Research Foundation of Korea (NRF-2018R1A2B3002001 to J.W.K and NRF-2019M3A9E2066882 to J.W.K).

Reference

  1. 1. Kim JB, Song WH, Park JS, Youn T-J, Park YH, Kim S-J, et al. (2021) A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia. PLoS ONE 16(1): e0245481. https://doi.org/10.1371/journal.pone.0245481 pmid:33481866

Citation: Kim JB, Song WH, Park JS, Youn T-J, Park YH, Kim S-J, et al. (2021) Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia. PLoS ONE 16(10): e0259072. https://doi.org/10.1371/journal.pone.0259072

Published: October 20, 2021

Copyright: © 2021 Kim et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.